Abstract:Abstract Background Subjective cognitive decline (SCD) may provide an early indicator of evolving neurodegenerative disease. Dyadic SCD patterns, or understanding the self/patient’s in relation to an informant/loved one’s endorsement of SCD, may more accurately reflect underlying Alzheimer’s disease (AD) pathology in particular. We related dyadic discrepancies in SCD to markers of core AD pathology, including amyloid‐β 42 (Aβ 42 ) and phosphorylated tau (p‐tau). Method Vanderbilt Memory and Aging Project participants free of clinical dementia [n = 150, 72±7years, 37% mild cognitive impairment (MCI)] and their informants completed the Everyday Cognition questionnaire. Dyadic discrepancy (self‐reported score minus informant‐reported score) was calculated. Positive scores indicate self>informant SCD and negative scores indicate informant>self SCD. Participants also underwent fasting lumbar puncture to obtain cerebrospinal fluid (CSF) for quantification of Aβ 42 and p‐tau. Linear mixed‐effects regression models related dyadic score to individual CSF biomarkers adjusting for age, sex, self‐reported race/ethnicity, cognitive status, apolipoprotein E‐ ε4 status (positive, negative), and depression symptoms (Geriatric Depression Scale) with false discovery rate (FDR) corrections for multiple comparisons. Models were repeated with a diagnosis x biomarker interaction. Result SCD discrepancy in the negative direction (informant>self‐SCD) was associated with higher CSF p‐tau (β = ‐0.64, pFDRself‐SCD) had lower Aβ 42 levels (β = 5.592, pFDR = 0.02), indicating more cerebral amyloid deposition. The opposite pattern was observed in cognitively unimpaired participants, though findings did not survive FDR correction (β = 1.16, p = 0.03, pFDR = 0.24). Additionally, in MCI participants, negative SCD discrepancy was associated with higher p‐tau levels (β = ‐0.7223, pFDR = 0.02). All significant results survived outlier exclusion. See Figure for details. Conclusion Dyadic SCD discrepancy correlates with AD biomarkers differently in preclinical and prodromal states. In MCI, greater informant‐SCD related to more amyloid and p‐tau deposition, likely due to patient anosognosia and increasing functional changes noted by others. Conversely, in an earlier, preclinical stage before the onset of overt problems, more self‐SCD appears indicative of greater amyloid pathology. Results are consistent with the purported pathological cascade of AD and highlight the relevance of considering dyadic SCD to inform underlying disease.

Differences regarding the five-factor personality model in patients with subjective cognitive decline and mild cognitive impairment

Premorbid personality traits as predictors for incident predementia syndromes: a multistate model approach

The relationship between personality and cognition in older adults with and without early-onset depression

Prevalence of Neuropsychiatric Symptoms Across the Declining Memory Continuum: an Observational Study in a Memory Clinic Setting

Five-factor model personality traits and cognitive function in five domains in older adulthood

Does personality affect the cognitive decline in aging? A systematic review

The impact of personality characteristics on the clinical expression in neurodegenerative disorders--a review

Associations between personality and psychological characteristics and cognitive outcomes among older adults.

Revised Temperament and Character Inventory factors predict neuropsychiatric symptoms and aging-related cognitive decline across 25 years

Personality traits and behavioral and psychological symptoms in patients at an early stage of Alzheimer's disease

Personality Impact on Alzheimer's Disease - Signature and Vascular Imaging Markers: A PET-MRI Study

Cognitive Profiles of Patients with Mild Cognitive Impairment or Dementia in Alzheimer's or Parkinson's Disease

Personality traits, cognitive states, and mortality in older adulthood.

Personality traits and cognitive reserve—High openness benefits cognition in the presence of age-related brain changes

Neuropsychological Testing Profiles of Patients with Alzheimer's Disease and Mild Cognitive Impairment: a Case-Control Study

Can cognitive assessment really discriminate early stages of Alzheimer's and behavioural variant frontotemporal dementia at initial clinical presentation?

Personality characteristics are independently associated with Personality characteristics are independently associated with prospective memory in the laboratory, and in daily life, among prospective memory in the laboratory, and in daily life, among older adults older adults

Neuroimaging Insights into Subjective Cognitive Decline: Differential Sensitivity of Cognitive Change Index and Everyday Cognition Scale

Sex-specific differences in neuropsychological profiles of mild cognitive impairment in a hospital-based clinical sample

Dyadic patterns of subjective cognitive decline relate to Alzheimer’s disease biomarkers differently in preclinical and prodromal clinical states

Four-year reciprocal relationships between personality and functional ability in older adults with and without sensory impairment: focus on neuroticism and agreeableness